News

New findings show when A3A is overexpressed, latent HIV is less likely to reactivate; the opposite is also true.

Health officials announced that individuals who consumed raw milk from Miller’s Biodiversity Farm may have been exposed to a drug-resistant strain of brucellosis.

Sink drains near toilets in hospital rooms could be reservoirs of antibiotic-resistant bacteria, a new study suggests.

A new study reports that Zika antibodies persist for longer than initially believed, with antibodies detected in symptomatic patients 18 months after illness onset.

Studies have shown high rates of inappropriate antibiotic prescribing and opportunity for improvement when it comes to ABSSSIs.

The FDA has granted orphan drug designation to APX001 for the treatment of cryptococcosis.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Pharmacists from across the US have authored a special feature to provide advice to clinicians looking to implement penicillin allergy skin testing (PAST) at their institution.

The US Food and Drug Administration has granted Breakthrough Therapy Designation to investigational drug CP101 for the treatment of patients with recurrent C diff infection.

Targeted marketing of PrEP has unintended consequences that could be avoided with improved messaging, a commentary in The Lancent says.

In a report detailing the hospitalization of a college student with complications from a herpes zoster infection, investigators say a corticosteroid prescription likely impaired the patient’s antiviral immune response.

Although the majority of states grant vaccine exemptions for medical reasons and religious beliefs, 17 states allow exemption for personal or moral beliefs, increasing the likelihood of outbreaks of preventable diseases like measles.

National Black HIV/AIDS Awareness Day is all about fighting the HIV stigma and encouraging education, testing, and prevention.

South Korean investigators have identified a correlation between infection with high-risk strains of HPV and increased risk of CVD, especially among women with obesity or other cardiovascular risk factors.

Paratek Pharmaceuticals has announced the launch of omadacycline, including 3 antimicrobial susceptibility tests and a surveillance program.

For individuals willing to self-collect specimens, staying on PrEP in order to avoid HIV infection may get significantly easier.

A phase 3 trial has been approved for SPR994, a candidate being developed as an oral carbapenem antibiotic for the treatment of cUTIs.

Is there a chance of similar legislation in the United States?

Post-licensure safety data on recombinant zoster vaccine (Shingrix) is consistent with pre-licensure clinical trial data, although the CDC cautions that the immunization is still in the “early uptake period.”

Japanese researchers find a concerning resistance to a new antiviral flu medication.

In an ongoing study spanning more than 15 years, investigators have made key discoveries about how HIV and TB drugs affect pregnant and postpartum women, leading to new safety and dosing recommendations for several medications.

The FDA has accepted an NDA for imipenem/cilastatin/relebactam as well as a supplemental NDA for ceftolozane/tazobactam.

Rutgers University investigators created a pictorial key that anyone with a strong enough microscope can use to correctly identify the Asian longhorned tick from other harmless species.

Whole-genome sequencing could speed up targeted treatment for patients infected with antibiotic-resistant bacteria, a proof of concept study by Johns Hopkins investigators determined.

Hospital visits for so-called “Victorian-era” diseases are on the rise in the United Kingdom, and experts there believe public health budget cuts may be behind the upswing.

Taking pre-exposure prophylaxis does not appear to lower the quality of life for people at risk of contracting HIV.

The long-term health care burden after Clostridium difficile (C diff) infection (CDI) is great for elderly patients. But even nonelderly patients are at risk for gastrointestinal symptoms for up to 2 years afterward.